Synspira Therapeutics
Robert K. Coughlin is a Managing Director at JLL and is the New England’s Life Science Practice Group lead. He specializes in the representation of lab, GMP manufacturing, and technology space. Robert delivers creative solutions that align real estate strategies with scientific business objectives. Robert most recently operated as the CEO of the Massachusetts Biotechnology Council, where his mission was to advance Massachusetts’s leadership in the life sciences to grow the industry. Robert has spent his career in both the public and private sectors. Before joining MassBio, he served as the Undersecretary of Economic Development within Governor Deval Patrick’s administration, where he prioritized both healthcare and economic development issues and was a strong advocate for the life sciences industry in Massachusetts. Prior to that, he was elected as State Representative to the 11th Norfolk district for three terms. Robert has also held senior executive positions in the environmental services, capital management, and venture capital industries.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Synspira Therapeutics
Synspira Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to significantly improving the lives of people with cystic fibrosis (CF) and other rare diseases.